MedPath

Santarus, Inc.

Santarus, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
1996-01-01
Employees
501
Market Cap
-
Website
http://santarus.com

Clinical Trials

9

Active:7
Completed:1

Trial Phases

2 Phases

Phase 1:1
Not Applicable:1

Drug Approvals

4

FDA:4

Drug Approvals

Glumetza

Approval Date
Mar 27, 2024
FDA

ZEGERID

Approval Date
Jul 19, 2023
FDA

Fenoglide

Approval Date
Jun 1, 2021
FDA

CYCLOSET

Approval Date
Nov 30, 2020
FDA

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 1
1 (50.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.